4//SEC Filing
Busch Matthew C. 4
Accession 0001127602-24-026627
CIK 0000318154other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 7:45 PM ET
Size
5.5 KB
Accession
0001127602-24-026627
Insider Transaction Report
Form 4
AMGEN INCAMGN
Busch Matthew C.
VP, Finance & CAO
Transactions
- Tax Payment
Common Stock
2024-11-05$316.91/sh−189$59,896→ 4,770 total
Footnotes (2)
- [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Plan): 43 RSUs which will vest on 4/30/2025; 509 RSUs which will vest on 11/5/2025; 144 RSUs which will vest in installments of 71 on 5/2/2025, and 73 on 5/2/2026; 296 RSUs which will vest in installments of 97 on 5/2/2025, 98 on 5/2/2026 and 101 on 5/2/2027; and 333 RSUs which will vest in installments of 109 on 5/7/2026, 110 on 5/7/2027, and 114 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F2]These shares include 90 Dividend Equivalents (DEs) granted pursuant to the Company's Equity Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001987926
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 7:45 PM ET
- Size
- 5.5 KB